Physician profile
Tabitha G Moe
NPI 1508067588
$181,614.53
in general payments reported to CMS, 2019-2025
15 companies · $52K in 2025
The $52K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2021: $90.02 · 2022: $22K · 2023: $38K · 2024: $69K · 2025: $52K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $146K · Travel and Lodging: $9,185 · Food and Beverage: $4,101 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $146,105.31 |
| Travel and Lodging | $9,184.50 |
| Food and Beverage | $4,100.71 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $88,707.74 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74,886.60 | 2022-2025 | Jardiance |
| Lilly USA, LLC | $14,715.34 | 2022-2025 | Jardiance |
| Medtronic, INC. | $1,966.53 | 2023-2025 | Harmony, Micra |
| Actelion Pharmaceuticals US, INC. | $508.84 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Abbott Laboratories | $245.79 | 2023-2024 | Cardiomems |
| Boston Scientific Corporation | $169.78 | 2021-2024 | Watchman Flx |
| Atricure, INC. | $114.36 | 2019 | |
| Edwards Lifesciences Corporation | $105.44 | 2025 | The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System |
| Janssen Pharmaceuticals, INC | $103.49 | 2019 | |
| Cardiva Medical, INC. | $73.12 | 2023 | Cardiva Vascade 5f Vcs |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.50 | 2023 | Lifevest |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabitha Moe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.